Sciele recorded pre-tax restructuring and Sular related charges of $8.9 million or $0.21 per share in the fourth quarter of 2007, related to the launch of ...
In March 2002, it acquired rights to distribute and sell the antihypertensive prescription medication Sular from AstraZeneca and Bayer Healthcare in the ...
Sciele recorded pre-tax restructuring and Sular related charges of $8.9 million or $0.21 per share in the fourth quarter of 2007, related to the launch of ...
The results for 2007 include $8.9 million in pre-tax restructuring and Sular related charges related to the launch of its new Sular formulation, ...
Additionally, Sciele Pharma said it plans to launch its new Sular formulation, in four dosage strengths, in the first quarter. Also in 2008, the company ...
The strong gain partly reflects the Food & Drug Administration's decision to approve a new formulation of Sular, the company's core hypertension treatment. ...
... Nuri Bilge Ceylan with "Kasaba" (The Small Town) and Kutluğ Ataman with "Karanlık Sular" (The Serpent's Tale) were some of these directors who achieved ...
... increases the amount of Lipitor in the bloodstream, which can increase adverse effects like muscle pain, weakness and stiffness. l Sular, a high blood ...
ASI suspended: Arun Pal Singh, SSP, on Wednesday suspended ASI Birbal Singh, in charge of Sular Gharat village police chowki, Dirba police station, ...
Jan 11, 2008 (Zacks Investment Research via COMTEX) -- SCRX | news | PowerRating | PR Charts -- Sciele is set to launch the new Sular in late February when ...